Invention Grant
- Patent Title: Live attenuated Leishmania vaccines
- Patent Title (中): 活减毒利什曼原虫疫苗
-
Application No.: US12946809Application Date: 2010-11-15
-
Publication No.: US08877213B2Publication Date: 2014-11-04
- Inventor: Hira L. Nakhasi , Angamuthu Selvapandiyan , Alain Debrabant , Robert C. Duncan , Poonam Salotra , Gannavaram Sreenivas
- Applicant: Hira L. Nakhasi , Angamuthu Selvapandiyan , Alain Debrabant , Robert C. Duncan , Poonam Salotra , Gannavaram Sreenivas
- Applicant Address: US DC Washington IN New Delhi
- Assignee: The United States of America as Represented by the Secretary of the Department of Health and Human Services,Indian Council of Medical Research
- Current Assignee: The United States of America as Represented by the Secretary of the Department of Health and Human Services,Indian Council of Medical Research
- Current Assignee Address: US DC Washington IN New Delhi
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K39/008
- IPC: A61K39/008 ; C12N1/36 ; C12N1/10 ; A61K39/00

Abstract:
Targeted disruption of the centrin gene leads to attenuation of growth in the Leishmania. Preferred embodiments of the invention provide attenuated strains of Leishmania useful for the preparation of immunogenic preparations including vaccines against a disease caused by infection with a virulent Leishmania strain and as tools for the generation of immunological and diagnostic reagents. Other preferred embodiments provide related immunogenic compositions, methods of generating an immune response, methods for producing a vaccine, and methods of forming attenuated strains of Leishmania.
Public/Granted literature
- US20110081383A1 LIVE ATTENUATED LEISHMANIA VACCINES Public/Granted day:2011-04-07
Information query